Pulmonary vasodilator therapy is associated with improved survival in COPD-PH with pulmonary vascular predominance

Abstract Pulmonary hypertension (PH) is a prevalent comorbidity associated with COPD accountable for increased mortality, exacerbation frequency, and progressive clinical course. Studies examining pulmonary vasodilator therapy in COPD-PH have shown mixed results, likely due to the heterogenous natur...

Full description

Bibliographic Details

Published in:	BMC Pulmonary Medicine
Main Authors:	Taylor Caton, Jay Pescatore, Mario Naranjo, Shameek Gayen
Format:	Article
Language:	English
Published:	BMC 2026-02-01
Subjects:	COPD Pulmonary hypertension Pulmonary vasodilator therapy
Online Access:	https://doi.org/10.1186/s12890-026-04203-4